How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies.

How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies. J Clin Oncol. 2021 Jan 12;:JCO2001616 Authors: Reagan PM, Neelapu SS PMID: 33434058 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33434058?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - January 12, 2021 Category: Cancer & Oncology Authors: Reagan PM, Neelapu SS Tags: J Clin Oncol Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma | Toxicology